Urinary 17-ketosteroids in diabetic and non-diabetic pregnancies.
The excretion of estriol into the maternal urine is an effective means of evaluating the fetus in pregnancies complicated by a number of metabolic disorders, such as chronic hypertension, renal disease, pre-eclampsia, etc. It is generally used in the management of pregnancies complicated by maternal diabetes mellitus even though some question has been raised as to its validity for this disorder. In this study we have evaluated estriol precursors in the form of 17-ketosteroids in the urine of pregnant women with mild diabetes mellitus as well as a non-diabetic control group. Urinary total estrogen excretion was also determined. Diabetics were found to excrete significantly higher amounts of 17-ketosteroids than the non-diabetic group. The possible significance of this finding in relation to the dynamics of estriol production in pregnancy is discussed.
D015068:17-Ketosteroids / Q000378:metabolism / Q000652:urine*; D004964:Estriol / Q000096:biosynthesis / Q000652:urine; D004967:Estrogens / Q000652:urine; D005260:Female; D006801:Humans; D011247:Pregnancy; D011248:Pregnancy Complications / Q000652:urine; D011263:Pregnancy Trimester, Third; D011254:Pregnancy in Diabetics / Q000652:urine*; D013997:Time Factors
D015068:17-Ketosteroids; D004967:Estrogens; D004964:Estriol